Covid-19Lessons taken from the coronavirus: redundant models instead of optimized can save us next time.
BiosimilarsAt least 255 pharmaceuticals playing biosimilars. Rise of the "Pharmerging"​ middle class.
Business Development8 (avoidable) mistakes made by pharmaceutical companies when entering European markets.
BiosimilarsAnti TNF biosimilars infliximab and etanercept conquer 63% and 44% of the Top 5 EU in under 3 years.
BiosimilarsBiosimilars following same pattern as generics? Neupogen keeps just 6% of EU market after 10 years.
